Colorado Is Testing Potential New Model for Revamping Health Care
The health care crisis continues to rage across the U.S. While investors watch insurance company stocks anxiously ahead of the election, people who can’t afford access to care watch their vital signs with even higher levels of stress. Thousands of Americans continue to die each year due to lack of access.
Now, Colorado hopes to turn the tide with a potential new health care model that the nation could follow. The proposed measures represent a step toward government-run health care, but wouldn’t disrupt the current industry as significantly as a massive shift to that model. If the plan succeeds, the state could prove as a testing ground for larger nationwide initiatives to confront the growing crisis.
What Colorado Is Proposing
When Gov. Jarid Polis came into office in 2019, he made addressing health care costs one of his top priorities. Within his first month on the job, he created the Office of Saving People Money on Health Care. During the subsequent four-month-long marathon legislative session, lawmakers pushed through a decade’s worth of old bills designed to bring relief to consumers.
One measure state lawmakers have already enacted is a reinsurance bill that shields insurance companies from the costs associated with treating the sickest patients. The move resulted in a 20% drop in 2020 premiums for Coloradans who purchase their insurance through the marketplace. Additionally, legislators took measures to cap out-of-network costs when patients receive care at hospitals that aren’t in their insurance networks. They also established an arbitration process for billing disputes.
People who live in metropolitan coastal areas often struggle to understand how vast certain regions of the nation are, and how this size prevents access to care. The distance creates a lack of partner physicians who can provide clinical oversight and a shortage of subspecialty expertise. Additionally, many rural and independent hospitals struggle to get costs reimbursed in a timely enough manner to continue operations as usual. These shortages directly impact the quality of patient care.
A Public Option
One of the most substantial problems facing Americans is how to pay for the high cost of care if their employers fail to offer them insurance. Additionally, people with disabilities who get denied when they apply for benefits often go without necessary coverage while they wait for a judge to approve their claims. Going without needed care poses significant health risks. Minor problems that doctors could fix simply and affordably often blossom into devastatingly expensive and potentially deadly headaches when neglected.
A public option would provide a stepping stone toward more government involvement in health care, although the Colorado model still allows for insurance industry involvement. The plan would cap administrative costs at no more than 15%. The program would operate similarly to Medicare — only anyone of any age could participate.
Reining in Prescription Drug Costs
Another problem contributing to the health care crisis in America is the soaring cost of prescription drugs. The Colorado legislature took action to cap the price of insulin at $100 to prevent unnecessary deaths from diabetes. It also approved the importation of lower-cost drugs from Canada and is awaiting federal approval on the plan.
Criticisms of the Plan
The plan isn’t without critics. For example, proponents of a Medicare for All-style health plan argue that the federally run Medicare program features administrative costs averaging just over 1%, not 15%. They also say that a public option will create a caste system of sorts, with those who rely on the public option waiting longer for care and receiving substandard services.
The hospital industry, too, weighed in with disapproval. The plan includes rate setting to keep institutions from charging more to privately insured patients. Administrators argue that they need to charge more to these individuals to make up for budget shortfalls from reimbursements from Medicare and Medicaid. However, the result is that patients with high deductibles and copays often avoid the emergency room even when they need it, fearing an unexpected bill.
Nevertheless, Colorado is making strides in providing accessible health care. Any interventions to prevent the senseless deaths occurring annually deserve applause.
Making Health Care More Affordable and Accessible for All Americans
America faces a health care crisis, and Colorado is one state that is leading the way in addressing it. Other states can follow its lead if society hopes to improve the lives of Americans who are living without insurance.
The Health Care Crisis is a Price problem and we have a Price problem because we have a supply problem.
Even if health care was free* for the next year, the problems we’d see addressed are the problems created by red tape and an inability to manage risk after a huge number of people explain that they have reevaluated the amount of risk they’re willing to accept.Report
No post for this but i’m seeing research on the twitters that docs are finding some anti malarial drugs are proving useful in treating COVID. Speeding up recovery and lessening symptoms. These are old drugs that are widely available.
Hopefully this pans out but until then up with science. Good news and hope is, you know, good.
Noah Smith @Noahpinion has more details.Report
Last night I was pointing to this article.
ScienceDirect paper
A few initial experiments indicates that it works in a dish, so it should block entry of the virus into lung cells. The drug, Camostat Mesilate, is already used in Japan to treat pancreatitis, and it’s also used for cancer and liver disease. About two-dozen companies there make it under a dozen different brand names, and a bottle of 100 pills (100 mg each) sells for $35. (But the one Japanese source I checked was sold out last night, so I couldn’t put any in my shopping cart.)
But it’s not FDA approved, so over here some bureaucrat will probably say it won’t be available here until long after the last Covid-19 victim is lowered into the ground. But I wouldn’t be surprised if they quickly try it overseas and find out if its really a magic bullet against the virus. If so, I’m sure Trump will make the FDA wave some procedures so we can start using it immediately.Report
I’m sure if it works it will be fast tracked. There are already compassionate use programs. In this case if they work we’ll see them given away almost as freely as Halloween candy.Report
One is left wondering why we don’t just adopt Canadian manufacturing practices, seeing as how their drugs are so much cheaper but still acceptable.
Or is there some magic in the land of the red maple that makes them able to produce drugs at lower cost?Report
We can’t, because we have rules to make sure our drugs are safe and effective. Canada has rules too, but their rules probably make sense.
Many years ago I was programming an automated transfer car for Torpharm (Toronto Pharmaceuticals).
The car is like a robot trolley that runs up and down a set of railroad tracks, stopping at various pallet lanes to pick up or drop off pallets of raw materials. I had it all debugged and working fine, so they signed off on it and said their next step was to delete all my code.
Me: “Uh, delete my code? Why? The code works fine.”
“Because some of the drugs we’ll make could be shipped to the US, and under FDA rules we’re not allowed to have even one line of code written until we spend six months describing what the code will do, once we start writing it.”
Me: “That’s insanely stupid.”
“Yes it is.”
Me: “But it’s just a transfer car. It doesn’t make anything. It doesn’t touch any chemicals.”
“But it’s a machine used in the production of drugs, so it has to conform to FDA guidelines.”
Me: “So the factory is ready now, but you can’t use it for six months?”
“No. We can’t start writing the code to make the factory work for six more months. The factory is probably years away from actually being up and running.”
It’s an example of bureaucracy run amok. One of the millwrights on the job said he’d worked constructing an FDA approved distribution center in the Carolinas. He spent a couple years there, assembling the conveyor system and then tearing it back out because the FDA had mandated some minor change. Under the rules, if there’s any change in requirements they had to start the construction all over again, from scratch. He said he took that conveyor apart and put it back together three times, and loved doing it because he was getting paid a whole lot of money.Report
gotta be honest with you, I am okay with government inspections being psychopathically anal when it comes to quality manufacturing of pharmaceuticals. If there’s one thing that I want to be five-nines sure that it’s clean and will work, it’s drugs.
We could go round-and-round on the degree of effort spent on “telling people not to do anything until the FDA says it’s okay” versus that spent on “making sure it’s okay”, but I’m not gonna say these guys shouldn’t have that attitude. I mean, in this circumstance I’d expect you to say “no production until we’ve done our review” and then you work twenty-five hours a day reviewing, but I don’t want there to not be a review.Report
Canadian drugs aren’t cheaper because they have better manufacturing practices; they’re cheaper because of price controls on patented drugs. Generic drugs are actually substantially cheaper in the US than in Canada.Report
Suggesting that we could do the same thing as reimportation for less money by instituting price controls.
Of course, this begs the question of why we just don’t have price controls already, and why we’ll be allowed to reimport drugs but not institute price controls.Report